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Manyanticancerdrugsactivatecaspasesviathemitochondrialapoptosispathway.Activationofthis
pathway triggers a concomitant bioenergetic crisis caused by the release of cytochrome-c (cyt-c).
Cancer cells are able to evade these processes by altering metabolic and caspase activation
pathways. In this study, we provide the ﬁrst integrated system study of mitochondrial bioenergetics
and apoptosis signalling and examine the role of mitochondrial cyt-c release in these events.
In accordance with single-cell experiments, our model showed that loss of cyt-c decreased
mitochondrial respiration by 95% and depolarised mitochondrial membrane potential DWm from
 142 to  88mV, with active caspase-3 potentiating this decrease. ATP synthase was reversed under
such conditions, consuming ATP and stabilising DWm. However, the direction and level of ATP
synthase activity showed signiﬁcant heterogeneity in individual cancer cells, which the model
explained by variations in (i) accessible cyt-c after release and (ii) the cell’s glycolytic capacity. Our
results provide a quantitative and mechanistic explanation for the protective role of enhanced
glucose utilisation for cancer cells to avert the otherwise lethal bioenergetic crisis associated with
apoptosis initiation.
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Introduction
Cytochrome-c (cyt-c) is a key component of the mitochondrial
respiratory chain, located in the intermembrane space (IMS)
and responsible for transporting electrons from respiratory
complex III to complex IV. By converting the redox potential
established by glycolysis and the tricarboxylic acid cycle
(TCA) into a proton gradient across the inner mitochondrial
membrane, cyt-c is required to maintain polarisation of the
mitochondrial transmembrane potential (DCm). In turn, DCm
establishes a proton-motive force for the (FoF1-)ATP synthase
to produce ATP (oxidative phosphorylation—OXPHOS;
Mitchell, 1961; Nicholls and Ward, 2000), which preserves
the cycling of Na
þ,C a
2þ,K
þ,C l
  ions and protons acrossthe
mitochondrial and the plasma membranes to maintain ionic
and osmotic homeostasis and to prevent necrotic cell death
(Nicholls, 1977; Nicholls and Budd, 2000).
To induce cancer cell death, chemotherapeutic agents often
generate conditions such as genotoxic stress that lead to cyt-c
release from the mitochondrial IMS into the cytosol, a process
referredtoasmitochondrialoutermembranepermeabilisation
(MOMP). This disrupts the mitochondrial respiratory chain
and causes DCm depolarisation, which in turn can result in a
bioenergeticcrisischaracterisedbyATPdepletion,lossofionic
homeostasis, increased osmotic pressure and necrotic cell
death (Jurgensmeier et al, 1998; Nicholls and Budd, 2000;
Dussmann et al, 2003a). In addition, cyt-c release is also a
direct transducer of apoptotic signals. Its presence in the
cytosolenablestheformationoftheapoptosome,aheptameric
complex of the cytosolic apoptotic protease-activating factor-1
and caspase-9 (Liu et al, 1996; Kluck et al, 1997), which
activateseffectorcaspases,inparticularcaspase-3(Srinivasula
et al, 1998; Slee et al, 1999).
However, many cancer cells have developed strategies
to survive both consequences of cyt-c release. Some cancer
cells bypass caspase-dependent apoptosis through loss-of-
function mutations or overexpression of caspase inhibitors.
While the molecular mechanisms and systems aspects of
impairment of caspase-dependent cell death are quite well
understood (Deveraux and Reed, 1999; Rehm et al, 2006;
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cells can survive, despite cyt-c release-induced bioenergetic
crisis, remain more elusive. The complexity of bioenergetic
pathways can barely be captured by traditional studies
that focus on a single metabolite or protein at a time. More-
over, interdependencies between mitochondrial and cellular
bioenergetics and caspase-dependent cell death have been
identiﬁed (Matsuyama et al, 2000; Ricci et al, 2003), posing
the need for their coinvestigation in a holistic approach. In
this report, we present the ﬁrst integrated systems biology
study of mitochondrial bioenergetics and apoptosis and
bridge the gap between metabolic modelling and a single-cell
experimental analysis. We developed a computational model
that integrates existing knowledge frommetabolic engineering
(Beard 2005; Korzeniewski and Brown, 1998) with our
recently established, ordinary differential equations (ODEs)
based model of the mitochondrial apoptosis pathway (Rehm
et al, 2006; Huber et al, 2007).
Our approach and ﬁndings are summarised by the chart
shown in Figure 1. Challenging the model with single-
cell experiments, we remodelled the kinetics of mitochondrial
depolarisation after cyt-c release in the presence or absence
of caspase activation. Mathematical modelling and experi-
mental validation identiﬁed glycolysis and variations in
the amount of cyt-c that remains accessible for respiration at
the mitochondria to be the key factors in determining
the ability of cancer cells to prevent a bioenergetic crisis
post-cyt-c release.
Results
Model calibration to in vitro data for ATP-
producing and non-ATP-producing mitochondria
We devised our model with gradually increasing complexity
and thus started with the widely studied experimental system
of isolated mitochondria. We assembled the network of
electrochemical reactions consisting of mitochondrial respira-
tion, ATP production and ion transport, and used a ﬁxed
NADH/NAD disequilibrium as model input (Figure 2, and
Materialsandmethodssection).ByMonte-Carloscreening,we
calibrated the model into three scenarios that have been
experimentally well described. These were (i) ATP producing
(‘state-3’) mitochondria in buffered medium of an ATP/ADP
ratio of 3:1 (75% ATP, 25% ADP), (ii) non-ATP producing,
resting-state (‘state-4’) mitochondria (100% ATP, no ADP) and
(iii) a situation where we considered mitochondria to change
from state-3 to state-4 (Supplementary Figure 1A). Further
details on the model construction and its calibration can be
found in Supplementary Text I.
Our best ﬁt led to a respiratory control ratio (state-3/state-4
respiration ratio) of 6.5:1, which is in agreement with reported
values of 5–10 (Nicholls, 1974a,b; Nicholls and Ward, 2000).
DCm values were calculated to be  157mV for state-4 and
 137mV for state-3, consistent with literature values of DCm
from  140 to  150mV (Nicholls and Budd, 2000) and with
a reported 10–15% increase in DCm polarisation when
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ment (Nicholls, 1974). Transmembrane DpH between the
mitochondrial matrix and the mitochondrial IMS was calcu-
lated as 0.41 for state-3 and 0.32 for state-4 (Supplementary
Figure 1B). In the case where we modelled state-3 to state-4
transitions, we achieved ATP replenishment within 2min in
accordance with the well-established rapid kinetics of ATP
production, where a 90% equilibrium was reached in
about 1min (Pfaff et al, 1969; Supplementary Figure 1C for
ATP/ADP ratio 1D for respiration ﬂux and DCm, 1E for ATP
synthase proton ﬂux and activity of constitutive proton leaks
over time). A detailed sensitivity analysis of the inﬂuence
of model parameters (Supplementary Table VII) on calibration
results is given in Supplementary Figure 2. A parameter
cluster analysis (Gutenkunst et al, 2007) allowed to character-
ise the model mechanistic and identiﬁed four principal
components that explain 94% of the model parameter
variations (Supplementary Figure 3). Further details on the
model mechanistic and sensitivity analysis can be found in
Supplementary Text II.
Cyt-c release impairs respiratory ﬂux and leads to
mitochondrial depolarisation
Mitochondrialcyt-creleasefollowingMOMPisconsideredasa
point of no return in the mitochondrial apoptosis pathway.
Loss of cyt-c disrupts the mitochondrial electron transport
chain between complex III and IV, depolarises DCm and
impairs ATP production. Once in the cytosol, cyt-c leads to
activation of the apoptosome-dependent cell death pathway
and caspase-3 activation (Green and Kroemer, 2004). How-
ever, evidence has been presented that mitochondria and
cellular bioenergetics can recover after the release of cyt-c,
particularly when effector caspase activation is impaired
(Waterhouse et al, 2001; Dussmann et al, 2003a; Colell
et al, 2007). These studies suggested that cells can survive a
MOMP-dependent energy crisis subsequent to cyt-c release.
We used the model to investigate the effect of cyt-c release
on respiration and DCm in the presence or absence of active
caspases. Cyt-c release was modelled to start at time t¼10min
after assuming cells in equilibrium. The kinetic parameters of
cyt-c releasewereextractedfrom previous single-cell measure-
ments (see Materials and methods section; Goldstein et al,
2000; Luetjens et al, 2001; Waterhouse et al, 2001; Dussmann
et al, 2003a, Figure 3A, dotted green line). We assumed re-
equilibration of cyt-c between the IMS and the cytosol, and
therefore concluded that a ﬁnal cyt-c fraction of 0.1%
remained accessible for respiration (see Method section).
We have hitherto denoted this cyt-c fraction as ‘respiration-
accessible cyt-c’.
We further modelled cyt-c to induce apoptosome formation
and to activate caspase-3 after release. Therefore, we included
our previously established model of mitochondrial apop-
tosis (Rehm et al, 2006) as a code subroutine and calculated
the level of active caspase-3 over time. The model predicted
caspase-3 activation and deactivation of complex I/II as
previously reported (Ricci et al, 2003; Figure 3A, solid
back and blue dashed lines, respectively) within 10–15min
of cyt-c release.
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Figure 2 Computational model of mitochondrial bioenergetics during cyt-c release and apoptosis. Interactions and transport processes between the mitochondrial
matrix (‘Matrix’), mitochondrial intermembrane space (‘IMS’) and the cytosol (‘Cytosol’). Roman numbers indicate single-cell processes that inﬂuence mitochondrial
bioenergetics: (I) model of mitochondrial apoptosis (according to Rehm et al, 2006) that activates caspase-3 upon cyt-c release; (II) cytosolic ATP production and
consumption; (III) active caspase-3 cleaving complex I/II; (IV) cyt-c release. Metabolite and ion ﬂuxes of mitochondrial bioenergetics are given by Arabic numbers:
(1) input function (NADH/NAD disequilibrium¼45.8:1); (2–4) respiration complexes I/II (considered together), III and IV; (5) ATP synthase; (6) adenosine nucleotide
transferase (ANT); (7) mitochondrial inner membrane proton leaks; (8) passive transport of adenosine phosphates and anorganic phosphate trough the outer
mitochondrial membrane; (9) phosphate–proton cotransport and (10) proton–potassium antiport.
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was decreased after onset of cyt-c release to 5% within 10–
15min, while a further decrease to 1% was observed when
caspase-3 was active (see Supplementary Figure 4A for a
mechanistic scheme and 4B for results). Depolarisation to a
remnant DCm of  88 or  76mVwas evident in the absence or
presence of active caspase-3, respectively (Figure 3B). DCm
depolarisation after cyt-c release and further depolarisation
by active caspase-3 were robust over a wide range of model
parameter variations (see Supplementary Figure 5 and
Supplementary Text II for a sensitivity analysis).
To validate the kinetics of DCm depolarisation and the effect
ofactivecaspase-3incellulo,weperformedsingle-cellimaging
experiments using HeLa cells expressing cyt-c–green ﬂuores-
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Figure 3 Live cell imaging and computational modelling of cyt-c release and mitochondrial depolarisation in HeLa cells expressing cyt-c–GFP. (A) Remodelling of
experimentally observed cyt-c release at time point t¼10min (Goldstein et al, 2000; Waterhouse et al, 2001; Dussmann et al, 2003a) with a half-time of 1.5min and a
remnant value of 0.1% (green dotted line), asdescribed inthe text, leads to active caspase-3 (black solid line) and deactivation of complex I/II (according to the model of
Rehmetal,2006) within15–20min afteronsetofcyt-crelease(bluedashed line).(B)Calculateddepolarisation ofmitochondrial membranepotential asaconsequence
ofcyt-creleaseasgivenin(A)withorwithoutcaspase-3-inducedcomplexI/IIcleavage(dashedredandsolidblueline).(C,D)Representativesingle-celltracesofHeLa
cells expressing cyt-c–GFP incubated with 30nM TMRM and exposed to 3 mM staurosporine (STS). (C) Traces of cyt-c release as indicated by the decrease in the s.d.
of average GFP pixel intensity and mitochondrial depolarisation measured by the average pixel intensity of TMRM (both normalised to initial values) of the two labelled
cells in (E). (E) Fluorescence images of cyt-c–GFP release followed by TMRM depletion, which indicates depolarisation of DCm. Residual TMRM staining is lost after
addition of FCCP. Scale bar, 10mm. (D, F) As in (C, E), but in the presence of 100mM of the caspase inhibitor zVAD-fmk administrated 1h prior to exposure to 3mM
STS. Source data is available for this ﬁgure at www.nature.com/msb.
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methyl rhodamine methyl-ester (TMRM). Cyt-c release was
induced with 3mM of the broad-spectrum kinase-inhibitor
staurosporine (STS). Indeed, these experiments suggested
a greater degree of mitochondrial depolarisation in the
absence of a broad-spectrum caspase-inhibitor Z-Val-Ala-Asp
(O-methyl)-ﬂuoromethylketone (zVAD-fmk; Figure 3C and E)
than in its presence (Figure 3D and F). This indicates a role of
caspase-3 in DCm depolarisation after cyt-c release, although
the inﬂuence of changes in plasma membrane potential on
TMRM redistribution upon caspase activation cannot be
excluded (Dussmann et al, 2003a).
Insummary,thesingle-cellmodelmechanisticallydescribed
and quantiﬁed DCm depolarisation as measured in living
cells subsequent to cyt-c release. Moreover, it suggested that
an additional complex I/II cleavage may further impair
respiration and DCm.
Characterisation of ATP synthase reversal as a
stabiliser of DWm
Maintenance of DCm subsequent to cyt-c release is essential
for ionic homeostasis within the cell and thus may prevent the
onsetofnecroticcelldeath(Nicholls,1977;NichollsandBudd,
2000). Reversal of ATP synthase has been proposedto stabilise
DCm by pumping protons from the matrix into the IMS, while
consuming instead of generating ATP (Goldstein et al, 2000;
Chinopoulos and Adam-Vizi, 2009). However, it has also been
reported that DCm can stabilisein theabsence ofATP synthase
reversal. We therefore aimed to investigate whether and under
what conditions ATP synthase reversal was present and if so
whattheimplicationson cytosolicATPandDCmwere.Weﬁrst
conﬁrmedthatATPsynthaseactivity wasreversed10minafter
onset of cyt-c release when respiration-accessible cyt-c
decreased to 0.1% in our model (Figure 4A, blue solid line).
This was slightly more pronounced when caspase-3 deactiva-
tion of complex I/II was also taken into consideration
(Figure 4A, red dashed line). Moreover, our model conﬁrmed
that ATP synthase reversal consumed ATP (Supplementary
Figure6A),thatglycolysispreventedATPdepletionduringthis
reversal (Supplementary Figure 6B) and that ATP synthase
reversal was robust when model parameters (Supplementary
Table VII) were increased or decreased over a ﬁvefold
parameter range (Supplementary Figure 7A and Supplemen-
tary Text II).
We then examined whether ATP synthase reversal stabilised
DCm, as was previously suggested (Rego et al, 2001;
Dussmann et al, 2003a). We therefore set ATP synthase
activity to zero in our single-cell model at 30min after onset of
cyt-c release. Inhibition of the reversed ATP synthase (as in
Figure 4A) predicted the occurrence of a further mitochondrial
depolarisation from  88 to  65mV ( 76 to  26mV when
considering complex I/II inhibition by caspase-3, Figure 4B).
Owing to the lower DCm and a resulting lower electrostatic
barrier for proton pumping through respiratory complexes, a
slight regain of respiratory ﬂux (Supplementary Figure 6C)
was also detected.
To experimentally validate the presence of reversed ATP
synthase, we added 5mM of the ATP synthase inhibitor
oligomycintoHeLacyt-c–GFPcellssubsequenttocyt-crelease.
Indeed, oligomycin induced a further DCm depolarisation
within 30min (Figure 4C and D) indicating reverse ATP
synthase activity, albeit in only 20% of a total of 237 cells
(n¼6 experiments). Overall, 65% of cells showed no detect-
able reaction. Strikingly, about 15% even showed a partial
repolarisation immediately after administration of oligo-
mycin (Figure 4E) suggesting that ATP synthase was main-
tained in forward mode in these cells. In all cells, the
protonophore carbonyl cyanide-p-triﬂuoromethoxyphenylhy-
drazone (FCCP) could fully depolarise DCm to negligible
levels, demonstrating that mitochondria maintained a remnant
DCm.I nc o n c l u s i o n ,A T Ps y n t h a s er e v e r s a lw a sf o u n di ns o m e
cellsto stabiliseDCmby consuming ATPafter cyt-crelease, yet an
unexpectedly wide cell-to-cell heterogeneity was observed with
regard to the direction of ATP synthase activity.
Respiration-accessible cyt-c subsequent to MOMP
inﬂuences activity and direction of ATP synthase
To explain this experimentally detected cell-to-cell hetero-
geneity in ATP synthase activity and direction, we modelled
that individual cells within a population have heterogeneous
levels of respiration-accessible cyt-c subsequent to cyt-c
release. As an example, cells maydiffer by the volume fraction
of mitochondria per cell, which leads to varying amounts
of cyt-c staying in the vicinity of the respiratory chain after
re-equilibration between IMS and cytosol. Model results
suggested that cells with respiration-accessible cyt-c levels
o0.7% of the initial concentration showed reversed activity
(Figure 4F, marked as ‘reverse’), whereas those that retained
1.2% or higher of their original cyt-c level maintained ATP
synthase activity in ATP forward mode (Figure 4F, marked as
‘forward’). The fraction of cells with levels of accessible cyt-c
between 0.7 and 1.2% were calculated to have no signiﬁcant
ATP synthase activity (Figure 4F, marked as ‘No act’).
Availability of bioenergetic substrates determines
ATP synthase activity and direction subsequent to
MOMP
The above modelling results suggested that the levels of
respiration-accessiblecyt-cafterreleaseinﬂuencethedirection
oftheATPsynthase.ThemodelfurtherwouldsuggestthatATP
synthase directionality is linked to glycolysis, as reverse ATP
synthase consumes glycolytically produced ATP (Supplemen-
tary Figure 6A and B). Therefore, we next studied the
dynamics of ATP synthase activity and DCm in the absence
of glycolysis. To this end, we performed single-cell imaging
experimentson HeLa cells exposedto 3 mM STSand measured
cyt-c–GFP and DCm in the absence of glucose, but in the
presence of sodium pyruvate as a substrate for the mitochon-
drial TCA. Cells were treated with oligomycin subsequent to
MOMP to evaluate in which direction ATP synthase was
working.Undertheseconditions,weobservedthatoligomycin
led to a repolarisation of DCm in 49 out of 67 cells. This
indicated that ATP synthase was maintained in forward mode
in the majority of cells (n¼3 experiments; see Figure 5A for
single-cell kinetics, Figure 5B for images). On average, B12%
Mitochondrial bioenergetics and apoptosis signalling
H J Huber et al
& 2011 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2011 5FCCP
C
y
t
-
c
 
G
F
P
 
s
.
d
.
 
o
f
 
p
i
x
e
l
 
i
n
t
e
n
s
i
t
y
 
(
%
)
T
M
R
M
 
a
v
e
r
a
g
e
 
p
i
x
e
l
 
i
n
t
e
n
s
i
t
y
 
(
%
)
0
50
100
0
50
100
Oligomycin
180 240 300 360
Cell 2
Cell 1
A
A
T
P
 
s
y
n
t
h
a
s
e
 
p
r
o
t
o
n
 
f
l
u
x
 
(
m
m
o
l
/
s
)
0 1 02 03 04 05 06 0
Time (min)
Cyt-c-
release
Direction change
0
–30
–60
–90
–120
–150
Δ
Ψ
m
 
a
f
t
e
r
 
6
0
 
m
i
n
 
(
m
V
)
 
Cyt-c release Cyt-c release
Time (min)
ATP synthase
inhibition
F
C
C
P
DIC TMRM
O
l
i
g
o
m
y
c
i
n
136
336
324
316
287
215
214
213
212
Time
(min)
ATP synthase
inhibition
STS + zVAD
0
–1
1
2
3
B
CD
F
E Forward
Reverse 
20%
15%
65%
-
-
-
-
-
 
 
-
 
-
 
 
-
 
 
-
 
-
Time (min)
- -
-
-
-
-
-
-
ATP synthase proton flux (mmol/s)
0
50
100
0 0
0
0.5
1.0
1.5
2.0
10 20 30 40 50 60 10 20
x %
Time (min)
R
e
s
p
i
r
a
t
i
o
n
 
a
c
c
e
s
s
i
b
l
e
 
C
y
t
-
c
 
(
%
 
i
n
i
t
i
a
l
)
Cyt-c release
No activity
With complex I/II cleavage
W/o complex I/II cleavage
With complex I/II
cleavage
W/o complex I/II
cleavage 
F
o
r
w
a
r
d
 
 
n
o
 
 
r
e
v
e
r
s
e
 
A
c
t
i
v
i
t
y
2.5 2.0 1.5 1.0 0.5 0
Cyt-c GFP
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(C, D) Representative single-cell microscopic imaging of HeLa cells expressing cyt-c–GFP incubated with 30nM TMRM and 100mM caspase inhibitor zVAD-fmk 1h
prior to exposure to 3mM staurosporine (STS). Five mM oligomycin was added as indicated. See text for further details on heterogeneous experimental outcome.
(C) Fluorescent images of cyt-c–GFP release followed by TMRM depletion, which indicates depolarisation of DCm. Residual TMRM staining is lost after addition of
FCCP. Scale bar, 10 mm. (D) Traces of cyt-c release as indicated by the decrease in the s.d. of average GFP pixel intensity and mitochondrial depolarisation measured
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by oligomycin responsiveness (237 cells, n¼6 experiments). (F) ATP synthase proton ﬂux before and after cyt-c release (t¼10min) according to the model in (A), with
retention of 0.1% up to 2% respiration-accessible cyt-c. Calculations indicate a stable reversal of ATP synthase for o0.7% (blue regions) and ATP synthase in forward
mode (light green to yellow) for more than 1.2% remaining respiration-accessible cyt-c. Source data is available for this ﬁgure at www.nature.com/msb.
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Figure 5 DCm Dynamics induced by oligomycin after release of cyt-c are glucose dependent. (A, B) HeLa cells expressing cyt-c–GFP were incubated with 30nM
TMRM, 2mM sodium pyruvate in medium without glucose and 100mM zVAD-fmk 1h prior to the addition of 3mM STS. Five mM oligomycin was added after cyt-c
release, followed by the addition of 10mM FCCP 30min later, as indicated by the white and black arrows, respectively. Single-cell traces and time-lapse images are
representative for 49 out of 67 cells in n¼3 experiments. (A) Single-cell kinetics of two representative cells. Diamonds show data from the cell shown in (B). (B)
Representative ﬂuorescent images associated with (A). Scale bar, 10 mm. (C) Difference between the average ﬂuorescent intensity in TMRM before and after 5mM
oligomycin addition in cell populations cultured with or without glucose. Oligomycin was added at least 15min after onset of cyt-c–GFP release. While ATP synthase
reversal was prominently present for cells in medium containing 5.5mM D-glucose as indicated by the decrease in TMRM ﬂuorescence, the cells depleted of D-glucose
showed an increase in the TMRM average pixel intensity, indicating a slight repolarisation (difference between bars is signiﬁcant, independent samples t-test, variances
notequal,Po0.05).(D)ModellingofATPsynthaseactivitydependentontimeandrespiration-accessiblecyt-cincellsequivalenttoFigure4f,butwithoutglycolysis.The
ATP synthase reversal only brieﬂy occurs until the cellular ATP reservoir is depleted. The ATP synthase can still produce ATP when the respiration-accessible cyt-c is
41% of its initial value and if the mitochondrial energy metabolism has enough substrate (e.g., through TCA cycle, sodium pyruvate). Source data is available for this
ﬁgure at www.nature.com/msb.
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glucose after treatment with oligomycin, whereas cells in
5.5mM glucose media, in contrast, showed a decrease of
B17% in the signal (Figure 5C). Setting glycolytic ATP
production to zero (Jprod ¼0) while maintaining cytosolic
ATP consumption (Jcons¼ xATPC *ATP, Equation (1)), the
model indeed conﬁrmed that cells in pyruvate medium
maintain ATP synthase in forward mode (Figure 5D). Under
the assumption of the same cell-to-cell variability in respira-
tion-accessible cyt-c after release as for cells in glucose
medium (0–2% of initial cyt-c), reversal was calculated to
occur only transiently between t¼20–40min and to occur only
in cells with 0.2% or less cyt-c remaining accessible for
respiration (Figure 5D versus Figure 4F). Consequently, cell
populations in low or no glucose media can be expected to
show a tendency to either maintain forward or to cease ATP
synthase activity after cyt-c release rather than maintaining
stable ATP synthase reversal.
High glucose induces repolarisation of DWm in
HeLa cells with inhibited caspases subsequent
to cyt-c release
An important conclusion from our modelling above was that
glycolytic ATP production determines the dynamics of ATP
synthase and thereby inﬂuences post-release bioenergetics in
HeLa cells. Indeed, the switch from mitochondrial to cytosolic
ATP production is a hallmark of cancerogenesis (Vander
Heiden et al, 2009). To further explore this mechanistically,
we modelled cells after cyt-c release assuming that glycolysis
maintainedcellularATPatvarying levelsfrom480%. We ﬁrst
considered a scenario with 0.1% respiration-accessible cyt-c
and synthase reversal. In this study, the model predicted that
subsequenttocyt-crelease,anelevationofcytosolicATPlevels
through increased glycolysis would increase ATP synthase
reversal, leading to a higher proton efﬂux from the matrix
and in this way partially restores DCm (Figure 6A). When
assuming 5% respiration-accessible cyt-c after release, where
ATP synthase operates in forward mode, an elevation of
cytosolic ATP from 80–100% led to a partial decrease in ATP
synthase in forward activity, leading to a lower proton inﬂux
intothematrixandalsotoarepolarisationofDCm(Figure6B).
Thus, we concluded that in both scenarios ATP increase can
repolarise DCm either by increasing ATP synthase reversal or
decreasing its forward activity. Sensitivity analysis proved
both recovery mechanisms stable over a broad range of
model parameter variations (Supplementary Figure 7C, D and
Supplementary Text II).
To validate these model predictions experimentally, we
treated HeLa–cyt-c–GFP cells with high extracellular glucose
post-cyt-c–GFP release. Using a glucose-FRET single-cell
reporter (Takanaga et al, 2008), we conﬁrmed that cytosolic
levels of glucose increased when extracellular glucose was
elevated from5.5to 25mM,indicatinga higherglucose uptake
(Supplementary Figure 8A). Likewise, we detected a higher
lactate production in STS-exposed HeLa cells exposed to
25mM compared with 5.5mM, demonstrating that the
enhanced glucose uptake resulted in increased glucose
utilisation (Supplementary Figure 8B).
We next investigated whether elevated glucose was capable
of stabilising DCm subsequent to cyt-c release. At ﬁrst, we
incubated HeLa–cyt-c–GFP cells in 25mM high glucose media
for 1h and subsequently induced cyt-c release with 3mM
STS in the presence of 100mM zVAD-fmk. The remnant DCm
detectedsubsequent to cyt-c releasewassigniﬁcantly higherin
cells incubated with 25mM glucose than in such with 5.5mM
glucose or glucose-free medium (Supplementary Figure 8C).
To investigate whether elevated glucose led to stabilisation of
DCm even when added subsequent to cyt-c release, we
maintained HeLa–cyt-c–GFP cells in medium supplemented
with sodium pyruvate in the absence of glucose and in the
presence of zVAD-fmk, and induced apoptosis with 3mM STS.
After cyt-c release, we increased the glucose concentration
from 0 to 25mM in the extracellular medium and monitored
the effect of this on DCm. Strikingly, we observed a signiﬁcant
increase in TMRM ﬂuorescence intensity from 18.6±1.6 to
46.9±1.4 (% relative to a value of 100% before cyt-c release)
averaged over 196 cells from three independent experiments
(Figure 6C and E), indicating a partial DCm repolarisation.
A similar level of repolarisation was also detected in HeLa
cells that were not transfected with cyt-c GFP (Supplementary
Figure 9).
We ﬁnally tested the hypothesis that the above recovery
mechanism is particularly prominent in cancer cells when
compared with non-transformed cells. MCF-7 breast cancer
cells expressing cyt-c–GFP (Luetjens et al, 2001) and treated
with STS to induce apoptosis showed a quantitatively similar
response as HeLa cells subsequent to cyt-c release. Addition of
25mM glucose to an originally glucose-free, sodium pyruvate-
containing medium led to a signiﬁcant (Po0.05) B2.5-fold
increase of TMRM average pixel intensity from 19.7±1.4%
Figure 6 Glycolysis stabilises DCm subsequent to cyt-c release in the absence of active caspases. (A) Modelled DCm repolarisation via higher glycolytic ATP and
increased ATP synthase reversal. Cells were assumed to retain 0.1% respiration-accessible cyt-c after release (which was associated with ATP synthase reversal) and
different cytosolic ATP levels were considered to be established by glycolysis (calculations for ATP between 80–99%). Elevated cytosolic ATP led to higher
ATPsynthasereversal(leftpanel)causingDCmincrease(right panel)overalmosttheentirerange. (B)DCmRepolarisation viahigherglycolyticATPandreducedATP
consumption.ModelispresentedasinFigure6a,yetretaining5%respiration-accessiblecyt-ctopreserveforwardATPsynthaseactivityaftercyt-crelease.ATPderived
from increased glycolysis led to a reduction in ATP synthase activity (left panel) until it has ceased and thus resulted in less proton inﬂux into the mitochondrial matrix
(left panel). As a consequence, decreased proton consumption by ATP synthesis resulted in a partial DCm repolarisation. (C–E) HeLa cyt-c–GFP cells incubated with
2mM sodium pyruvate in the absence of glucose and exposed to STS in the presence of zVAD-fmk. Following cyt-c-induced mitochondrial depolarisation, 25mM
glucose was added to the medium. (C) Representative traces of a cell with cyt-c–GFP release and recovery of DCm measured by TMRM. (D) Comparison of the
average TMRM ﬂuorescence in cell populations subsequent to cyt-c release before and 30min after addition of 25mM glucose to medium without glucose supply. The
signiﬁcantly higher TMRM ﬂuorescence in the latter scenario indicates a partial DCm repolarisation (196 cells out of three experiments). (E) Cyt-c–GFP and TMRM
ﬂuorescence as well as DIC channel images during depolarisation and recovery for a typical cell. Scale bar, 10mm. Source data is available for this ﬁgure at
www.nature.com/msb.
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(n¼167 cells). In contrast, non-transformed human epithelial
CRL-1807 cells expressing cyt-c–GFP did not show a signiﬁ-
cant repolarisation after cyt-c release (7.0±1.6 to 10.7±2.4%,
N¼21 cells) when culture medium was changed from pyruvate to
25mM glucose (see Supplementary Figure 10A, B for a typical cell
response), suggesting thatcancercells are preferentiallycapable of
undergoing glucose-induced recovery of DCm.
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Systems model of bioenergetic consequences
of cyt-c release
Understanding the mechanistic details of how cancer cells are
able to resist apoptotic and metabolic consequences of ther-
apeutically induced cyt-c release can provide strategies to
increase treatment efﬁciency and reduce clinical relapse. While
cancer cells are able to evade apoptosis by impairing caspase
activity by loss-of-function mutations or increased expression of
their antagonists, the mechanisms by which they can survive
energy crisis after metabolic impairment is a matter of extensive
current research (Vander Heiden et al, 2009).
Combining computational modelling with single-cell micro-
scopy, we provided the ﬁrst systems studyof cellular bioenergetics
subsequent to cyt-c release. We integrated approaches from
metabolic engineering (Beard, 2005; Beard and Qian, 2007; Dash
and Beard, 2008) and apoptosis signalling (Rehm et al, 2006;
Huber et al,2 0 0 7 ) ,g r a d u a l l yi n c r e a s e dm o d e lc o m p l e x i t y ,a n d
eventually used it as a predictive tool. To this end, we remodelled
bioenergetic state variables in isolated mitochondria, described
DCm depolarisation subsequent to cyt-c release in the presence or
absence of effector caspases, and characterised ATP synthase
reversal as a consumer of cytosolic ATP and a stabiliser of DCm.
We identiﬁed a cell-to-cell heterogeneity in the ATP syn-
thase direction subsequent to cyt-c release, which the model
explainedbyvariationsintheamountofrespiration-accessiblecyt-
c and the cell’s glycolytic capacity. Finally, our model demon-
strated that an increase in cytosolic ATP production as a
consequence of higher glucose levels can repolarise DCm in an
ATP synthase-dependent mannerand independent of its direction.
By incorporating data on cyt-c release kinetics from previous
single-cell studies, the model was ﬁrst able to correctly capture
the kinetics of DCm depolarisation observed in previous
single-cell experiments in HeLa cells (Waterhouse et al,2 0 0 1 ) ,
MCF7 breast cancer cells (Dussmann et al, 2003a), DU145
prostate cancer cells (Dussmann et al,2 0 1 0 ) ,a n dp r i m a r y
neurons (Nicholls and Ward, 2000). Furthermore, the model
allowed to quantify the impairment of respiration and DCm
values before and during release as well as the feedback of active
caspases to DCm (Ricci et al, 2003). As experimental techniques
to quantify respiration and in situ mitochondrial ATP production
in a single cell are still under development (Zhdanov et al, 2008;
Imamura et al, 2009), systems modelling can complement
existing experimental techniques to quantitatively predict
cause–effect relationships and validate the plausibility of
experimental results (Bentele et al, 2004; Rehm, et al, 2006;
Albeck et al, 2008; Lavrik, 2010).
ATP synthase direction after cyt-c release depends
on accessible cyt-c and the cell’s glycolytic
capacity and exhibits a wide heterogeneity within
a cell population
It was suggested previously that freely diffusing cyt-c into and
outoftheIMSmaycriticallydetermineDCmsubsequenttocyt-
c release. We modelled that a cyt-c fraction remains accessible
for respiration subsequent to release (‘respiration-accessible
cyt-c’). Our model suggested that small variations in such
levels signiﬁcantly account for the experimentally detected
population heterogeneity in the direction and amount of ATP
synthase proton ﬂux. Variations in respiration-accessible cyt-c
may arise from incomplete mitochondrial release. Such
incomplete release has been associated with failure of cristae
remodelling in the absence of the BH3-only family member
BID or the intramitochondrial protein OPA1 (Scorrano et al,
2002; Frezza et al, 2006). Even when re-equilibration between
the mitochondrial IMS and the cytosol is assumed to be
complete, different amounts of volume fractions of mitochon-
dria in a cell may result in different cytosolic cyt-c levels after
cyt-c release.
The amount of ATP produced by glycolysis was found to
be another key determinant for ATP synthase direction
subsequent to cyt-c release. Cell populations with a reduced
capabilitytoproduceATPbyglycolysiswerepredictedtoshow
a tendency to maintain forward or to show no ATP synthase
activity, rather than reversal of ATP synthase activity. Indeed,
in cells cultured in pyruvate instead of glucose, which were
therefore unable to produce ATP by glycolysis, ATP synthase
reversal was barely detected. We summarise the inﬂuence of
respiration-accessible cyt-c and the cell’s glycolytic capacity to
determine ATP synthase direction within a cell population
subsequent to cyt-c release in the state-space diagram in
Figure 7A. Typically, individual cells of a population have a
large heterogeneity in ATP synthase direction (grey boxes)
with one group showing ATP synthase reversal (indicated by
‘1’), another one having ATP synthase in forward mode (‘2’),
while others do not showany detectable ATP synthase activity
(cells close to the dashed line). Cells in a medium with sodium
pyruvate, but lacking glucose, are not able to produce ATP by
glycolysis and therefore cannot meet the ATP demand needed
for mitochondria to maintain stable ATP synthase reversal. All
ATP that was produced before cyt-c release will be eventually
used up and ATP synthasewill cease orswitch back to forward
mode. On a population level, less and less cells will be found
withreverseATPsynthaseasATPdepletes(directionindicated
by the black arrow).
Increased glucose utilisation leads to partial DWm
repolarisation
Green and colleagues (Waterhouse et al, 2001) speculated that a
sufﬁciently high cyt-c concentration in the vicinity of mitochon-
dria may lead to repolarisation of DCm and in this way may
contribute to a cellular recovery from bioenergetic crisis. Our
model indeed suggested that such a recovery is possible, but
requiresanactivemechanism,inourcaseanincreaseincytosolic
ATP production by elevated rate of glycolysis.
The proposed mechanism is summarised in Figure 7B. For
cells that have ATP synthase working in reverse mode after
release (indicated by ‘1’, as in Figure 7A), elevated ATP
production after glucose addition leads to increased proton
efﬂux from the matrix and thus partially repolarise DCm.
Likewise, cell populations that can maintain ATP synthase in
forward mode in low-glucose medium (denoted by ‘2’) also
increase DCm upon glucose addition.
By exposure of HeLa cells to high extracellular glucose
levels, we were able to increase glucose uptake and its
utilisationconsistentwithpreviousstudiesinHeLaandINS-1E
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conﬁrmed that high glucose was able to stabilise (cells
maintained in high-glucose media) and/or to repolarise (cells
where glucose was added subsequent to release) DCm
consistent with above model predictions. While we conﬁrmed
this stabilisation and recovery also in MCF7 breast cancer
cells, no signiﬁcant effect of elevated glucose was found in
non-transformed CRL-1807 cells. In conjunction with an
impairment ofcaspase-dependent cell death observed in many
humancancers,thismechanism may providecancercellswith
a competitive advantage to evade cell death induced by
anticancer drugs or other stress conditions when compared
with non-transformed cells.
How do cancer cells achieve an increase in glucose uptake
and utilisation? Interestingly, it has been demonstrated that
mitochondrial impairment and hypoxia transcriptionally
elevate glucose transporter isoform GLUT1 levels (Ebert
et al, 1995) in HeLa cells arguing also for a medium-term
adaptation to stress situations. Elstrom et al (2004) have
shown that LN5.12 murine prolymphocytic cells increase their
glycolytic rate to stabilise DCm when the prosurvival serine/
threonine kinase AKT was induced (Elstrom et al, 2004).
The same group also reported that AKT overexpression
maintains a physiological DCm under growth factor with-
drawal(Plasetal,2001).OtherstudiesreportedthatHeLacells
increase their turnover of the glycolytic machinery through
upregulation of the rate-limiting glycolytic enzymes GAPDH
and phosphofructokinase (PFK1) (Chesney et al, 1999; Colell
et al, 2007), or switch between OXPHOS and glycolysis upon
growth medium changes (Rossignol et al, 2004).
While this study has focused on the consequences of cyt-c
release on mitochondrial bioenergetics, our model can also
be exploited to study the dependency of caspase activity on
cytosolic pH (Matsuyama et al, 2000) and to investigate
the inﬂuence of ATP levels on apoptosome formation and
mitochondrial apoptosis (Zou et al, 2003). Likewise, it can be
extended to include detailed mechanistic on glycolysis, the
TCA cycle (Wu et al, 2007), autophagy, or production of
reactive oxygen species (Atlante et al, 2000). As novel cancer
therapeutics address multiple targets in apoptotic as well as
metabolic pathways (Lessene et al, 2008), such cross-talk
models may become an essential tool for in silico prediction of
their therapeutic effectiveness both in terms of triggering
programmed cell death and in overcoming bioenergetic rescue
mechanisms.
Materials and methods
Cell culture and transfection
Generation and characterisation of human HeLa D98 cervical
carcinoma cells or MCF7 breast cancer cells stably expressing a
cyt-c–GFP fusion protein have been described (Dussmann et al,
2003a). Non-transformed CRL-1807 cells were obtained from the
ATCC. HeLa cells were cultivated in RPMI, and CRL-1807 cells were
grown in DMEM at 371C in a humidiﬁed atmosphere at 5% CO2. Both
media contained 10% fetal bovine serum (FBS). CRL-1807 cells were
transfected with 1-mg plasmid DNA encoding for cyt-c–GFP, as
described (Luetjens et al, 2001), and 3ml/ml Lipofectamine 2000
(Invitrogen,Biosciences,Dublin,Ireland)andgrownfor2dayspriorto
the experiment. We have previously shown that cyt-c–GFP is imported
intomitochondriaandcoreleasedwithendogenouscyt-cafterselective
outer membrane permeabilisation with digitonin (Luetjens et al,
2001). Concomitant release of endogenous cyt-c and cyt-c–GFP from
mitochondria during apoptosis has also been demonstrated in other
reports (Goldstein et al, 2000; Munoz-Pinedo et al, 2006). Cell culture
ingredients were obtained from Sigma-Aldrich, Dublin, Ireland.
Live cell imaging
Cyt-c–GFP release was monitored by time-lapse confocal microscopy,
and mitochondrial membrane potential (DCm) was simultaneously
determined by the distribution of the monovalent cationic dye TMRM
(MobiTec, Go ¨ttingen, Germany) using an inverted confocal laser
scanning microscope (Fluoview 200, Olympus, Hamburg, Germany),
as described previously (Dussmann et al, 2003a; Rehm et al, 2003).
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argon laser and a 543nm HeNe Laser, a 488/543 dichroic beam
splitter, and a 63 1.4 NA oil immersion objective (LSM 510 and 710,
Carl Zeiss, Jena, Germany) were used. On the LSM 510, ﬂuorescence
emissionwassplitwitha540nmsecondarybeamsplitteranddetected
after transmitting a 505–550nm band-pass ﬁlter for GFP or a 560nm
long-pass emission ﬁlter for TMRM. On the LSM 710, the emission
beam path was adjusted so that GFP was detected in the range of
495–550nm and TMRM in the range of 565–750nm. Fluorescence
was detected from a 1-mm thick confocal section (full width
half maximum). For time-lapse imaging, culture dishes were
mounted onto the microscope stage that was equipped with a mini
incubator and objective heater (Pecon, Erbach, Germany). In control
experiments,constantﬂuorescencevaluesforcyt-c–GFPandTMRMas
well as a constant rate of cell divisions were detected over a period of
24h. For induction of apoptosis, cells were incubated with 3-mMS T S
(Axxora, Alpha Technologies, Blessington, Ireland) on the stage after
1h of equilibration with 30nM TMRM. Caspase activation was
inhibited by 1h preincubation with 100mM zVAD-fmk (Bachem,
Heidelberg, Germany). During the measurements, cells were treated
with oligomycin and FCCP (all from Sigma-Aldrich, Dublin, Ireland)
as indicated. Where required, glucose-free RPMI medium was
enriched with 10% FBS, 15mM HEPES (pH 7.4), and 2mM sodium
pyruvate. D-Glucose was added at concentrations of 5.5 or 25mM
added during time-lapse imaging at times as indicated. In order to
investigate the effect of enhanced glucose availability after MOMP,
glucose was added when at least 75% of cells had released cyt-c–GFP.
In order to prevent evaporation, the media was covered with
embryo-tested parafﬁn oil. Images were analysed using Metamorph
image processing software (Metamorph 7.1–7.6, Molecular Devices,
Wokingham, UK). The distribution of cyt-c–GFP was calculated
using the s.d. of the average pixel intensity as described previously
(Dussmann et al, 2003a), and decreases in the s.d. value indicate the
redistribution of GFP from punctuate (mitochondrial) to homo-
geneous (cytoplasm and nucleus) patterns. The average pixel
intensity of the TMRM signal represents the mitochondrial membrane
potential as described previously (Ward et al, 2000). Cells from
three to six separate experiments per condition were analysed, and
parameters were compared using Student’s t-test for paired samples or
independent samples with Po0.05 considered to be signiﬁcant (SPSS
15, LEAD Technologies, Chicago, USA).
Imaging of intracellular glucose concentration
HeLa cells were transfected with IMS–RFP, a sensor of MOMP,
(Albeck et al, 2008) and a glucose-sensitive CFP-Citrine FRET probe
FLII12Pglu-700uDelta6 (Takanaga et al, 2008, Addgene plasmid
17866), and were used for time-lapse imaging on the LSM510 Meta
confocal microscope. IMS–RFP release was observed with settings as
used for TMRM. The 405 laser and the 405/514 multichroic beam
splitter was used for CFP excitation, CFP emission and FRETchannel
were measured using the 470–500nm band-pass ﬁlter and the
505–550nm band-pass ﬁlter, respectively, separated by a secondary
dichroic beam splitter at 515nm. Citrine ﬂuorescence was detected
from optical slices of 3mm thickness at settings used for GFP. FRET/
CFP ratio images were following background subtraction, and an
increase in average pixel intensity indicated an increase in the
intracellular glucose concentration. Acceptor photobleaching was
negligible at the acquisition settings used. Image processing was
performed using MetaMorph software as described above. Cells were
incubated with growth medium supplemented with 15mM HEPES,
2mMsodiumpyruvate,30nMTMRM,100mMcaspaseinhibitorzVAD-
fmk, and 5.5mM D-glucose. Release of IMS–RFP was induced by
addition of 3mM STS. A quantity of 20mM D-glucose was added at
times as indicated in the ﬁgures.
Lactate assay
HeLa cells cultured in 96-well plates were treated with STS and
zVAD-fmk as above in the presence of 0, 5.5 or 25mM D-glucose, as
indicated. After 8h, extracellular media were removed and
stored at  801C. A 10ml sample was diluted 20-fold and assayed with
a Lactate Assay Fluorometric Kit (ab65330, Abcam plc, Cambridge,
UK), as per manufacturer’s protocol in a BIO TEK Synergy HT
ﬂuorometer (Winooski, Vermont, USA). Fluorescence values were
calibrated to a standard curve generated using lactate standard
supplied with the kit.
Computational model of mitochondrial
bioenergetics
We established a model to study the temporal behaviour of the
bioenergeticsstatevariablesDCm,ADP/ATPratio,respiratoryﬂuxand
ATP synthase activity (Figure 2). We focused on ﬂux through the
respiratory chain and ion transporters across the mitochondrial inner
membrane. Fluxes are speciﬁed by Arabic numbers and are described
here in sequential order. Respiration was driven by disequilibrium of
the NADH/NAD ratio (as is generated by the TCA cycle). Electro-
chemical ﬂux through mitochondrial complexes I/II, III and IV in IMS,
ATP synthesis, adenine nucleotide translocase, constitutive proton
leaks, proton–phosphate cotransport, K
þ/proton-exchanger and ATP
transmembrane transport were adapted from the literature (Korze-
niewski and Brown, 1998; Korzeniewski and Zoladz, 2003; Beard,
2005; Beard and Qian, 2007; Dash and Beard, 2008). Unlike above
reports, we also calculated all state variables for non-equilibrium
states and as a function of time.
Wecalibratedthispartofthemodeltoresultsobtainedfromisolated
mitochondria in different supporting media. These included a
‘buffered’ medium with a constant external ATP/ADP ratio of 3:1
(i.e., 25% ADP deﬁciency) to model mitochondria in ‘state-3’, a
mediumwith 100% ATPand 0% ADP to model mitochondria in ‘state-
4’, and one where an initial ATP deﬁciency of 25% was replenished by
mitochondrial ATP production to model a state-3 to state-4 ‘transition’.
As these scenarios have been extensively studied in the literature
(Nicholls and Ferguson, 1992; Nicholls and Budd, 2000; Ward et al,
2000; Kushnareva et al, 2002), we were able to ﬁx unknown model
parameters (input NADH/NAD disequilibrium, complexes I–IV, ATP
synthase and ATP transferase rates of activity) by Monte-Carlo
screening to render the experimental situation (see Supplementary
Text 1 for methods and results).
Modelling of cytosolic ATP, cyt-c release and
caspase-mediated complex I/II deactivation
We extended the above calibrated model of mitochondrial bioener-
getics and included cytosolic processes, assuming a mitochondrial
volume fraction of 1% in the cell (Poppe et al, 2001). We ﬁrst
implemented processes for cytosolic ATP turnover (ATP production
and consumption in the cytosol). Cytosolic ATP production was
modelled (ﬂux Jprod, glycolysis) by increasing the ATP concentration
in proportional to the amount of available ADP (ADP-ATP,
JprodBADP). This was balanced by ATP-consuming processes
(ﬂux Jcons), such as Na
þ/K
þ–ATPase activity and protein synthesis,
considered to be dependent on the level of available ATP (ATP-ADP,
JconsB ATP). Superposition of both effects led to a ﬂux
JATPC ¼ Jprod   Jcons ¼ xATPC  ð KATDP   ADP   ATPÞ: ð1Þ
KATDPequalsthecytosolicATP/ADPratioatequilibriuminacellwhen
mitochondriaaredisregarded. It was setto 3(ATP/ADP¼3:1,i.e., 75%
ATP; AMP neglected) to mimic cells under normal glucose and set to 0
for a pyruvate-only medium (consistent to Jprod¼0). To model variable
rates of glycolysis as in Figure 6, we directly ﬁxed ATP and ADP.
Combining the cytosolic (Equation (1).) and mitochondrial ATP
production, we adapted the ﬂux strength xATDP to 0.1980/s to yield
an equilibrium ATP/ADP ratio of 20:1 (95% ATP), as experimentally
observed in HeLa cells with intact mitochondria (Evans and
Kaplan, 1977).
Cyt-c release was modelled to start at the onset time trelease¼10min
after assuming cells in equilibrium. An exponential decay with half-
release time t1/2_cyt_c¼1.5min was remodelled from experiments
performed by our group and others (Goldstein et al, 2000; Luetjens
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the ﬂuxes
Jcytc tot;loss ¼ lnð2Þ=t1=2 cytc  ð cytcactual
tot ðtÞ cytcfinalÞ
Jcytc red;loss ¼ lnð2Þ=t1=2 cytc  ð cytcactual
red ðtÞ cytcfinalÞ; ð2Þ
which describe loss of total and reduced cyt-c (cytctot
actual, cytcred
actual) and
lead to a depletion of complex IV activity. We assumed a ﬁnal cyt-c
concentration cyt-cﬁnal to be accessible for respiratory complexes after
the release. This reﬂected the fact that even under unimpaired
cyt-c release, the cyt-c concentration in the mitochondrial IMS does
not drop to zero, but re-equilibrates between IMS and cytosol.
Assuming the IMS as 10% of the mitochondrial volume and a volume
fraction of 1% mitochondria in a cell (Dussmann et al, 2003a),
complete cyt-c release was therefore considered to lead to a ﬁnal
‘accessible’ cyt-c concentration that is 0.1% of its initial value.
Adifferent ratiowasused,whenimpaired cyt-c releasewas considered
(Figures 4F, 5D and 6B).
Caspase-3 has been reported to deactivate complex I and II of the
respiratory chain (Ricci et al, 2003). We modelled this deactivation by
the enzymatic reaction Q
activeþcasp3(t)-Q
inactive. This assumes that
active complex Q
active gets cleaved to its inactive form Q
inactive by
the amount of caspase-3 at a certain time t (casp3(t)), subsequent to
cyt-c release. This leads to the following loss-of-function ﬂuxes.
JCasp Qtot ¼ kcasp 3  ð Qactive
Qtot   QfinalÞ casp3ðtÞ
JCasp QH2 ¼ kcasp 3  ð Qactive
QH2   QfinalÞ casp3ðtÞð 3Þ
which modelled a disruption of the electron transfer from complex I/II
to complex III.
Total ubiquinone fractions QQtot
active and reduced ubiquinone fractions
QQH2
active were treated independently as they represented separate
degrees of freedom. A remnant fraction that remains active (Q
ﬁnal)
was assumed as 1% of the initial ubiquinone concentration.
Furthermore, kcasp-3 described the caspase-3 enzymatic cleavage rate
(set to 12mM/s; Stennicke et al, 2000)). The activation proﬁle of free
active caspase-3 (casp3(t)) over time was calculated using a network
of ODEs, as described previously by our group (Rehm et al, 2006).
Brieﬂy, concomitant cyt-c and Smac release subsequent to MOMP led
to apoptosome formation, which induced a cascade of caspase-9 and
caspase-3 activation.
Model code and data
The model was constructed by a system of ODEs that describe
temporal changes of metabolites, ions and biochemical parameters by
biochemicalﬂuxes.ThemodelcodewasimplementedinMATLAB(the
Mathworks,UK)andisgivenintheSupplementaryDatasetI.Codeuse
is described in Supplementary Text I. State variables of the model are
given in Supplementary Table I. Variables to control the code for
different biological situations are given in Supplementary Table II. The
ODE system is depicted in Supplementary Table III. The biochemical
ﬂuxes that are used to construct this ODE system are biologically
described in Supplementary Table IV and mathematically detailed in
Supplementary Table V. Biological constraints such as moiety
conservation are given in Supplementary Table VI. Model parameters
used in the study and discussed in the sensitivity analysis (Supple-
mentary Text II) are given in Supplementary Table VII, while physical
and chemical constants together with ion concentrations that are used
in the model are described in Supplementary Table VIII. Supplemen-
taryTableIXﬁnallydescribesthereactionnetworkusedforcalculating
caspase-3 activation over time.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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